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Abstract
Background: Sepsis is an overwhelming and life-threatening response to bacteria in bloodstream and a major
cause of neonatal morbidity and mortality. Understanding the etiology and potential risk factors for neonatal sepsis
is urgently required, particularly in low-income countries where burden of infection is high and its epidemiology is
poorly understood.
Methods: A prospective observational cohort study was conducted between April 2016 and October 2017 in a
level three NICU at a tertiary care hospital in Nepal to determine the bacterial etiology and potential risk factors for
neonatal sepsis.
Results: Among 142 NICU admitted neonates, 15% (21/142) and 32% (46/142) developed blood culture-positive
and -negative neonatal sepsis respectively. Klebsiella pneumoniae (34%, 15/44) and Enterobacter spp. (25%, 11/44)
were the most common isolates. The antimicrobial resistance of isolates to ampicillin (100%, 43/43), cefotaxime
(74%, 31/42) and ampicillin-sulbactam (55%, 21/38) were the highest. BlaTEM (53%, 18/34) and blaKPC (46%, 13/28)
were the commonest ESBL and carbapenemase genes respectively. In univariate logistic regression, the odds of
sepsis increased with each additional day of use of invasive procedures such as mechanical ventilation (OR 1.086,
95% CI 1.008–1.170), umbilical artery catheter (OR 1.375, 95% CI 1.049–1.803), intravenous cannula (OR 1.140, 95% CI
1.062–1.225); blood transfusion events (OR 3.084, 95% CI 1.407–6.760); NICU stay (OR 1.109, 95% CI 1.040–1.182) and
failure to breast feed (OR 1.130, 95% CI 1.060–1.205). Sepsis odds also increased with leukopenia (OR 1.790, 95% CI
1.04–3.082), increase in C-reactive protein (OR 1.028, 95% CI 1.016–1.040) and decrease in platelets count (OR 0.992,
95% CI 0.989–0.994). In multivariate analysis, increase in IV cannula insertion days (OR 1.147, 95% CI 1.039–1.267)
and CRP level (OR 1.028, 95% CI 1.008–1.049) increased the odds of sepsis.
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Conclusions: Our study indicated various nosocomial risk factors and underscored the need to improve local
infection control measures so as to reduce the existing burden of sepsis. We have highlighted certain sepsis
associated laboratory parameters along with identification of antimicrobial resistance genes, which can guide for
early and better therapeutic management of sepsis. These findings could be extrapolated to other low-income
settings within the region.
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Background
Neonatal sepsis refers to the clinical syndrome of a sys-
temic inflammatory response, which develops secondar-
ily to a proven or suspected infection in neonates [1].
While the incidence of sepsis ranges from 1 to 5 cases/
1000 live-births in high income countries (HICs), it is es-
timated to be at least 3 to 20 fold higher in low- and
middle- income countries (LMICs) [2]. In 2018, there
were 2.5 million neonatal deaths globally, with the ma-
jority occurring in Sub-Saharan Africa and South Asia;
15% of these deaths were associated with sepsis [3]. In
Nepal, neonatal sepsis is common and of the12,881 neo-
natal deaths that occurred in 2015, 18.4% were attrib-
uted to sepsis [4].
Immature immunity, preterm birth and very low birth
weight (< 1500 g) place neonates at increased risk of in-
fections. Many vulnerable newborns often require special
clinical care and admission to a neonatal intensive care
unit (NICU). Ironically, due to their unique vulnerability
coupled with hostile environmental factors of NICUs,
admission to an NICU is in itself a risk factor for the de-
velopment of hospital acquired infections (HAIs). Stud-
ies have shown that NICUs have a greater incidence of
infections compared to other neonatal units [5, 6]. Vari-
ous invasive modalities of therapeutic/supportive clinical
care used in NICUs such as parenteral feeding, mechan-
ical ventilation, and intravascular catheterization have
been shown to be associated with increased risk of neo-
natal sepsis [6].
Most of the published studies from Nepal on neonatal
sepsis are cross-sectional and/or retrospective using rou-
tine microbiology or NICU data and primarily address-
ing the bacterial and clinical characteristics only.
Longitudinal developmental studies aiming at rigorously
observing the neonates throughout their stay in NICU
would provide unprecedented opportunities to collect
real time data on predisposing factors associated with
neonatal sepsis, along with other valuable information
such as clinical-pathological characteristics, bacterial eti-
ology and associated antimicrobial resistance (AMR).
Understanding of such variables that are reflective of the
local scenario can provide crucial information required
for early diagnosis and effective treatment in addition to
developing best fitted preventive strategies. Such studies
are scarce in Nepal. Here, in this prospective cohort
observational study, we aimed to fulfill this gap by longi-
tudinally following up the neonates admitted to NICU in
a tertiary care hospital of Nepal in order to determine
the clinical-pathological features, potential risk factors,




Before carrying out the study, an ethical clearance was
taken from Nepal health research council (NHRC278/
2015) and Oxford Tropical Research Ethics Committee
(OxTREC 24–16). All methods were performed follow-
ing the ethical principles as stated by the Declaration of
Helsinki and in accordance to Good Clinical and La-
boratory Practices.
Setting and study design
This prospective observational cohort study was con-
ducted in a level three NICU of Patan Hospital, a tertiary
care referral teaching hospital of the Patan Academy of
Health Sciences, located in the Lalitpur Metropolitan
area of the Kathmandu valley. The eight bedded NICU
has a provision for admitting only those intensive care
requiring neonates that are born in Patan Hospital.
Within NICU, two beds are separated for a dedicated
ICU care of culture positive neonates. Neonates born
elsewhere are admitted to the pediatric intensive care
unit (PICU). Neonates without risk factors for sepsis are
admitted to a clean nursery, while those having under-
lying risk factors for, or evidence of infection are sent to
the septic nursery for observation and non-intensive
medical care.
Enrollment and follow up of the neonates
The parents/guardians of the neonates who were ad-
mitted to the NICU from April 2016 till October
2017 were approached for informed consent to take
part in the study. The consented neonates were en-
rolled and followed up on daily basis for development
of any signs of septicemia throughout their stay in
the NICU or until one of the final outcomes (dis-
charge, transfer to other department, death or left
without medical advice) was attained. All relevant
data on clinical, therapeutic and laboratory
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investigation were recorded in a pre-tested case re-
port form (CRF) by referring to the clinical note
marked by the pediatrician. Data were recorded onto
CliRes Data Management System. The integrity of
data entry was validated by double entry of the infor-
mation by two different individuals.
Inclusion and exclusion criteria
All consented neonates who were born in Patan hospital
during a sampling period of 1.5 years from April 2016 to
October 2017 and requiring admission to NICU were in-
cluded in the study. Those presenting with gross con-
genital abnormalities and those admitted or readmitted
to the NICU after being discharged from the hospital
were excluded.
Diagnosis of sepsis
Enrolled neonates were suspected of having sepsis based
on clinical signs and/or underlying risk factors as listed
in Additional file 1. Once suspected, relevant biological
samples were collected for sepsis screening tests as given
in Additional file 1 [7, 8]. Neonates were immediately
treated with empirical antimicrobial therapy according
to the neonatal treatment guidelines of Patan hospital
(Additional file 2). As per the NICU protocol adopted by
Patan hospital, sepsis was diagnosed as culture positive
sepsis if the blood culture was positive in a patient with
clinical signs of sepsis. Culture negative sepsis was diag-
nosed in the presence of clinical signs of sepsis but a
negative blood culture. The overall workflow for sepsis
diagnosis is outlined in Additional file 3. Neonates who
were not suspected of sepsis during their entire stay in
the NICU were designated as non-sepsis group. The ne-
onates who were clinically suspected of sepsis earlier,
but yielded negative results in both sepsis screen tests
and culture, along with improved clinical signs were
ruled out as sepsis cases and formed a part of the non-
sepsis group. For statistical comparative analysis, the
non-sepsis group was taken as the control group against
the blood culture positive sepsis group to identify the
risk factors for sepsis.
Microbiological investigation
One to two ml of peripheral blood samples were
drawn from the neonates clinically suspected of sepsis
and before the administration of antimicrobials. The
samples were aseptically injected into BD-BACTEC
Peds Plus/F culture vials (Becton Dickinson, UK) and
incubated in an automated BD BACTEC FX40 (Bec-
ton Dickinson, UK) culture system. Upon being
flagged as culture positive, small volume of blood was
aseptically aspirated with sterile syringe and inocu-
lated on 5% sheep blood agar, MacConkey agar and
chocolate agar. Bacterial identification was conducted
by standard microbiological methods and antimicro-
bial susceptibility testing (AST) was performed using
modified Kirby-Bauer disc diffusion method [9],with
inhibition zone sizes interpreted according to Clinical
Laboratory Standards Institute (CLSI) 2017 breakpoint
guidelines [10]. Gram-negative bacilli (GNB) that were
resistant (zone of inhibition ≤22 mm) or intermediate
(zone of inhibition 23-25 mm) to cefotaxime (30 μg)
were suspected as producing extended-spectrum beta-
lactamases (ESBL).
Confirmatory tests for ESBL and AmpC production
Phenotypic confirmatory tests for ESBL production were
performed using the combination disc diffusion method
[11] using a beta-lactam antimicrobial with and without
a beta-lactamase inhibitor (D62C, D68C, Mast group
Ltd., Liverpool, UK). The isolate was considered as ESBL
producer if the size of zone of inhibition in beta-
lactamase inhibitor supplemented disc was equal to or
more than 5mm as compared to the beta lactam alone.
For genetic test, the bacterial DNA was extracted from
an overnight culture of cryogenically preserved bacterial
isolates by heating at 90 °C for 10 min, followed by cen-
trifugation at 4000 rpm for 15 min. The supernatant was
used as template DNA for PCR assay. Multiplex PCR
was performed for detection of genetic markers associ-
ated with ESBL (blaCTX-M-1, 2, 9, 8/25 [12], blaTEM [13],
blaSHV [14], blaOXA [14]) and carbapenemase (blaKPC
[15], blaNDM-1 [16], blaOXA-48 [15], blaOXA-23, 24, 51, 58
[17]) mediated resistance (Additional file 4). Twenty-five
microliter of PCR master mix containing 1XPCR buffer,
1 unit Hotstart Taq DNA polymerase (Qiagen,
Germany),1.5 mM MgCl2, 0.2 mM dNTPs mix,0.1–
0.2 μM of each primers and 3 μl crude template DNA
were used for amplification. PCR conditions were 95 °C/
15min, followed by 35 cycles of 95 °C/40 s, annealing
temperature of 52–61 °C/40 s and extension at 72 °C/50 s
with final extension of 72 °C for 7 min. The PCR ampli-
cons were electrophoresed in 1.5% agarose gel and re-
sults were interpreted based on the presence of expected
product size as depicted by positive control.
Statistical analysis
Statistical analyses were conducted in SPSS (version
20.0). The descriptive statistics of qualitative variables
were expressed in absolute frequency (N) with percent-
age (%). That of quantitative variables was calculated in
mean ± standard deviation (SD) or median with inter-
quartile range (IQR). Odds ratio with 95% confidence
interval (CI) was calculated under univariate logistic re-
gression analysis. The significance threshold of p ≤ 0.05
was considered. Five independent variables that gave
highly significant p-values (< 0.001) in univariate analysis
were modeled using backward stepwise multiple logistic
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regression. In this process, only two variables remained
significant at the final stage.
Results
Demographic features
From April 2016 to October 2017, there were a total
of 11,779 live births in Patan hospital, of which 204
(1.73%) required admission to the NICU; 142 of
these neonates were enrolled in this study. The
demographic features of the enrolled neonates are
shown in Additional file 5. Briefly, among the 142
enrolled neonates, 59% (83/142) were preterm and
65% (93/142) were male; 16% (22/142) were of very
low birth weight (< 1500 g); 15% (22/142) and 18%
(26/142) required intubation and resuscitation re-
spectively immediately after birth. The majority of
deliveries (68%, 96/142) were cesarean and respira-
tory distress was common (55%, 78/142). The use of
various invasive and non-invasive devices of clinical
care was frequent. The median duration of NICU
stay and entire hospital stay were 7 days (IQR 4–12)
and 16 days (IQR 10–26), respectively. The use of
antimicrobials during the study period is shown in
Additional file 2. Over 90% of 142 enrolled neonates
received the first line antimicrobials (ampicillin and
amikacin), while 56 and 26% of enrolled cases re-
ceived cefotaxime and meropenem, respectively.
The burden and types of sepsis
Sepsis was clinically suspected in 49% (70/142) of the
enrolled neonates; while remaining 72 neonates didn’t
develop any signs of sepsis during their NICU stay.
Amongst total, 15% (21/142) and 32% (46/142) of en-
rolled neonates developed blood culture positive and
negative sepsis respectively. Later, due to improved
clinical condition and negative sepsis screen results,
three of the clinically suspected cases were ruled out
of sepsis, giving a total non-sepsis group of 75 neo-
nates. The 21 culture positive neonates yielded a total
of 44 blood culture positive sepsis events. Nine cases
developed single sepsis episode, three neonates devel-
oped two culture positive events and rest nine cases
developed more than three culture positive events
during the study period. For multiple blood culture
positive events caused by the bacteria of same genus
and similar antimicrobial susceptibility profile, they
could be either due to the persistence of earlier infec-
tion or re-infection by new bacterial strain. Eighty
percent (35/44) of culture positive sepsis events were
of late onset type (after 72 h of birth). Of total en-
rolled neonates, 14% (20/142) died during the study
period; eight of those who died had sepsis.
Microbiological results
A total of 118 blood samples were microbiologically in-
vestigated during the study period from the 70 enrolled
neonates who were clinically suspected of sepsis. Of 118
blood samples, 44 samples were culture positive, giving a
blood culture positive proportion of 37% (44/118). The
majority (89%, 39/44) of bacterial isolates was Gram
negative bacilli (GNB) with Klebsiella pneumoniae, En-
terobacter spp. and Acinetobacter spp. being the most
common, constituting 34% (15/44), 25% (11/44) and
18% (8/44) of the total isolates respectively. Gram posi-
tive cocci (GPC) were less common, with coagulase
negative Staphylococcus (CoNS) being the most preva-
lent GPC of total isolates (9%, 4/44) (Table 1). As per
the NICU protocol of Patan hospital, if the neonate ful-
filled the clinical criteria of sepsis, the isolation of CoNS
from neonatal blood samples is considered significant
and the neonate is treated accordingly.
The results of AST and ESBL confirmatory tests for
the bacterial isolates from blood are shown in Tables 2
and 3, respectively. Briefly, 72% (31/43) of bacterial iso-
lates were multi-drug resistant (resistant to three or
more different classes of antimicrobial agents). Overall,
100 and 37% of isolates were resistant to ampicillin and
amikacin respectively. Further, 74% (31/42), 55% (21/38)
and 34% (13/38) of the isolates were resistant to cefotax-
ime, ampicillin-sulbactam and meropenem, respectively.
In general, GNB were more susceptible to amikacin, cip-
rofloxacin and cotrimoxazole, while less susceptible to-
wards various beta-lactam antimicrobials, except
meropenem. Twenty one percent (7/34) of GNB isolates
were phenotypically confirmed to be ESBL producers, of
which Klebsiella spp. contributed 40% (6/15). Overall,
Table 1 The bacteriological profile of neonatal blood culture
samples shown by number and percentage
Bacterial isolates n %
GNB
Klebsiella pneumoniae 15 34.1
Enterobacter spp. 11 25.0
Acinetobacter spp. 8 18.2
E. coli 3 6.8
Klebsiella oxytoca 1 2.3
Pseudomonas spp. 1 2.3
Total GNB 39 88.6
GPC
CoNS 4 9.1
S. aureus 1 2.3
Total GPC 5 11.4
Total (All isolates) 44
GNB Gram negative bacilli, GPC Gram positive cocci, CoNS Coagulase
negative Staphylococcus
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blaTEM (53%, 18/34) and blaKPC (46%, 13/28) were the
most common ESBL and carbapenemase genes respect-
ively in GNB. Ninety four percent (14/15) and 47% (7/
15) of Klebsiella spp. had blaTEM and blaNDM-1 respect-
ively; 73% (8/11) of Enterobacter spp. had blaKPC and
83% (5/6) of Acinetobacter spp. had blaOXA-51 resistance
gene. All isolates tested negative for blaIMP and blaVIM
genes.
Risk factors associated with the occurrence of neonatal
sepsis in NICU
In order to identify potential predictors of sepsis in our
setting, odds ratio was calculated by univariate logistic re-
gression for various neonatal, maternal, laboratory and en-
vironmental factors (Table 4). The analysis was based on
75 non-sepsis and 21 culture proven sepsis cases. - Of sev-
eral origins of potential exposure factors analyzed,
majority of the factors that stood out to be statistically sig-
nificant were found to be related to the nosocomial expo-
sures. Overall, we found that every single day increase in
the use of various invasive devices like mechanical ventila-
tion (OR 1.086, 95% CI 1.008–1.170, p = 0.030), UAC (OR
1.375, 95% CI 1.049–1.803, p = 0.021), UVC (OR 1.325,
95% CI 1.047–1.676, p = 0.019), IV cannula (OR 1.140,
95% CI 1.062–1.225, p < 0.001),OG tube (OR 1.612, 95%
CI 1.038–2.503, p = 0.033) and every additional blood
transfusion events (OR 3.084, 95% CI 1.407–6.760, p =
0.005) were associated with increased odds of sepsis devel-
opment in the univariate logistic regression analysis. It
was also found that every additional day of stay in NICU
and hospital increased the risk of sepsis development with
odds ratios of 1.109 (95% CI 1.040–1.182, p = 0.002) and
1.097 (95% CI 1.031–1.167, p = 0.004) respectively. Simi-
larly, with every single day increase in failure to feed orally
Table 2 Antimicrobial resistance profile of bacteria isolated from blood samples, shown by proportion (percent)
GNB, n MDR AMP AMK GEN CTX CHL CIP OFX TS MEM SAM PTZ












































Acinetobacter spp., 8 5/7 (71) 7/7 (100) 3/7 (43) 3/7 (43) 6/7 (86) 6/7 (86) 3/7 (43) 2/7 (29) 4/7 (57) 3/7 (43) 4/7 (57) 2/7 (29)
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Total for GPC 4/5 (80) 5/5 (100) 3/5 (60) 4/5 (80) 3/4 (75) 1/5 (20) 4/5 (80) 3/4 (75) 1/2 (50) 4/4
(100)
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GNB Gram negative bacilli, GPC Gram positive cocci, CoNS Coagulase negative Staphylococcus, MDR Multi-drug resistant, AMP Ampicillin, AMK Amikacin, GEN
Gentamycin, CTX Cefotaxime, CHL Chloramphenicol, CIP Ciprofloxacin, OFX Ofloxacin, TS Cotrimoxazole, MEM Meropenem, SAM Ampicillin-Sulbactam, PTZ
Piperacillin-Tazobactam, ERY Erythromycin, CLI Clindamycin, OXA Oxacillin
Table 3 Results of confirmatory tests for ESBL and carbapenemase production, shown by proportion (percent)
Bacterial
isolatesd
Phenotypic test Molecular (PCR) testa
ESBL AmpC blaTEM blaCTXM-1
b blaSHV blaNDM-1 blaOXA blaKPC blaOXA-48 blaOXA-51
c
Klebsiella spp 6/15 (40) 1/15 (7) 14/15 (94) 7/15 (47) 5/15 (33.4) 7/15 (47) 6/15 (40) 5/15 (33) 7/15 (46.7) NA
Enterobacter spp. 1/11 (9) 1/11 (9) 4/11 (36) 2/11 (18) 0/11 (0) 0/11 (0) 4/11 (36) 8/11 (73) 3/11 (27.2) NA
Acinetobacter spp. 0/6 (0) 0/6 (0) 0/6 (0) 0/6 (0) 0/6 (0) 0/6 (0) 0/6 (0) NA NA 5/6 (83)
Grand Total 7/34 (21) `2/34 (6) 18/34 (53) 9/34 (26) 5/34 (15) 7/34 (21) 10/34 (29) 13/28 (46.4) 10/28 (36) 5/6 (83)
NA not tested
aAll tested isolates were negative for blaIMP and blaVIM
bAll tested isolates were negative for other blaCTXM family genes: blaCTXM-2, blaCTXM-8, blaCTXM-9, blaCTXM-25
cAll Acinetobacter spp. isolates tested negative for other blaOXA genes: blaOXA-23, blaOXA-24, blaOXA-58
dBoth E. coli isolates were negative for all AMR genes tested
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Table 4 Logistic regression analysis for determining odds ratio of potential risk factors for neonatal sepsis. The variable values for
each group are also shown
Variables Variable values mean (sd) or frequency (%) Logistic regression analysis
Culture-positive neonates Non-Sepsis neonates Odds ratio 95% CI p-value
Univariate analysis
Obstetric-peripartum features:
Maternal age, years 29.2 (sd 5.5) 27.6 (sd 4.9) 1.062 0.964–1.168 0.221
Labor pain, hours 4.3 (sd 2.2) 5.7 (sd 3.7) 0.828 0.552–1.242 0.363
Vaginal test, times 0.7 (sd 0.5) 0.8 (sd 0.9) 0.955 0.595–1.53 0.848
PPROM:
Absence 15 (70%) 60 (80%) 1 Reference
Presence 6 (30%) 15 (20%) 1.714 0.564–5.208 0.342
Induction of labor:
Not induced 16 (76%) 59 (79%) 1 Reference
Induced 5 (24%) 16 (21%) 1.133 0.356–3.566 0.832
Delivery mode:
Normal 5 (24%) 17 (23%) 1 Reference
Vaginal/assisted 2 (9%) 8 (11%) 0.85 0.135–5.366 0.863
C-section 14 (67%) 50 (67%) 0.952 0.298–3.037 0.934
Amniotic fluid color:
Clear 20 (95%) 63 (84%) 1 Reference
Meconium stained 1 (5%) 12 (16%) 0.263 0.032–2.158 0.214
Suctioning at birth:
No 15 (72%) 38 (50%) 1 Reference
Yes 6 (28%) 37 (50%) 0.4 0.14–1.144 0.087
Resuscitation at birth:
No 16 (76%) 60 (80%) 1 Reference
Yes 5 (24%) 15 (20%) 1.25 0.395–3.958 0.704
Intubation at birth:
No 16 (76%) 62 (83%) 1 Reference
Yes 5 (24%) 13 (17%) 1.49 0.463–4.796 0.503
Neonatal features:
Birth weight, grams:
> 2500 (Normal) 6 (29%) 35 (47%) 1 Reference
1500–2500 (Low) 10 (47%) 31 (41%) 1.882 0.613–5.777 0.269
< 1500 (Very low) 5 (24%) 9 (12%) 3.241 0.803–13.072 0.098
Gestational age, weeks 34.4 (sd 3.8) 35.8 (sd 3.6) 0.902 0.792–1.0278 0.121
Gender:
Female 9 (43%) 26 (35%) 1 Reference
Male 12 (57%) 49 (65%) 0.707 0.264–1.897 0.492
Lethargy, days 11.6 (sd 6.8) 6.6 (sd 5.3) 1.139 1.046–1.24 0.003
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(breast and spoon feeding) and conversely, enteral feeding
increased the risk of neonatal sepsis with odds ratios of
1.130 (95% CI 1.060–1.205, p < 0.001), 1.140 (95% CI
1.064–1.222, p < 0.001) and 1.163 (95% CI 1.059–1.278,
p = 0.002) respectively. In laboratory parameters, when
compared to normal WBC count range (7000–30,000/ μl),
leukopenia (< 7000 WBC/μl) was associated with in-
creased odds of sepsis (OR 1.790, 95% CI 1.04–3.082, p =
0.036). Similarly, decrease in platelets count and increase
in C-reactive protein level raised the odds of sepsis with
odds ratios of 0.992 (95% CI 0.989–0.994, p < 0.001) and
1.028 (95% CI 1.016–1.040, p < 0.001) respectively. In
multivariate analysis, increase in IV cannula insertion days
(OR 1.147, 95% CI 1.039–1.267, p = 0.006) and CRP level
(OR 1.028, 95% CI 1.008–1.049, p = 0.006) increased the
odds of sepsis.
Discussion
In this prospective longitudinal cohort study on NICU
admitted neonates, we found a high burden of sepsis
(15% culture positive and 32% culture negative sepsis),
80% of culture positive sepsis events being of late onset
type and 89% being caused by GNB, with Klebsiella
pneumoniae being the most common (34%, 15/44) iso-
lates. Nearly three quarters of the bacterial isolates were
MDR and nearly half of the isolates contained the ESBL
Table 4 Logistic regression analysis for determining odds ratio of potential risk factors for neonatal sepsis. The variable values for
each group are also shown (Continued)
Variables Variable values mean (sd) or frequency (%) Logistic regression analysis
Culture-positive neonates Non-Sepsis neonates Odds ratio 95% CI p-value
Neonatal laboratory features:
WBC count (×10^3/μl):
Normal (7–30) 12.5 (sd 6.2) 14.7 (sd 6.2) 1 Reference
Leukopenia (< 7) 4.8 (sd 6.2) 4.9 (sd 6.4) 1.79 1.040–3.082 0.036
Leukocytosis (> 30) 32 (sd 13.8) 41.8 (sd 10.2) 0.154 0.019–1.216 0.076
Platelets (×10^3/μl) 129 (sd 130) 234 (sd 114.7) 0.992 0.989–0.994 0.000
CRP level (mg/dl) 72.0 (sd 72.5) 14.8 (sd 28.1) 1.028 1.016–1.040 0.000
Therapeutic/supportive care features:
Transfusion, times 4.7 (sd 4.1) 1.5 (sd 0.6) 3.084 1.407–6.76 0.005
UAC insertion, days 26.5 17.6 1.375 1.049–1.803 0.021
UVC insertion, days 31.2 19.9 1.325 1.047–1.676 0.019
IV cannula, days 19.6 (sd 8.4) 11.1 (sd 6.8) 1.14 1.062–1.225 0.000
Foley’s insertion, days 9.8 (sd 7.1) 7.5 (sd 5.2) 1.064 0.956–1.184 0.257
Intubation, days 11 (sd 8.1) 6.6 (sd 6.2) 1.086 1.008–1.170 0.03
OG tube insertion, days 15.5 8.1 1.612 1.038–2.503 0.033
NG tube insertion, days 2.7 2.2 1.07 0.972–1.177 0.168
Neonatal feeding features:
Not breast fed, days 17.1 (sd 9.6) 8.6 (sd 6.5) 1.13 1.060–1.205 0.000
Not spoon fed, days 16.7 (sd 8.5) 8.5 (sd 6.4) 1.14 1.064–1.222 0.000
Enteral fed, days 9.3 (sd 7.2) 4.7 (sd 4.1) 1.163 1.059–1.278 0.002
Outcome:
NICU stay, days 16.1 (sd 9.3) 8.9 (sd 6.7) 1.109 1.040–1.182 0.002
Hospital stay, days 23.9 (sd 10.1) 14.9 (sd 9.1) 1.097 1.031–1.167 0.004
Final outcome:
Survived 1 Reference
Dead 4 (22%) 12 (18%) 1.333 0.369–4.817 0.661
Multivariate analysis
IV cannula insertion, days 1.147 1.039–1.267 0.006
CRP level (mg/dl) 1.028 1.008–1.049 0.006
CRP C-reactive protein, IV Intravenous, NG Naso-gastric, OG Oro-gastric, PPROM Prolonged premature rupture of the membrane, sd standard deviation, UAC
Umbilical artery catheter, UVC Umbilical vein catheter
Significant p-values are shown in bold fonts
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and carbapenemase genes blaTEM and blaKPC. Further,
we found that every additional day of insertion of vari-
ous invasive devices, failure to oral feeding and stay in
NICU as well hospital increased the odds of sepsis
development.
The burden of neonatal sepsis may vary within a set-
ting by time and between settings depending on the dif-
ferences in local epidemiology of sepsis. Also, probably
due to differences in study design and definitions, the
prevalence of culture positive sepsis reported from vari-
ous neonatal units in South Asia varied widely from 6 to
57%, compared to 15% in this study [18–22]. We found
the majority (80%) of culture proven episodes to be of
late onset type suggesting horizontal transmission to be
main mode of infection, as compared to other Asian
countries [23, 24]. Alternatively, studies from Pakistan
and Bangladesh reported higher prevalence of early on-
set sepsis suggesting more vertical transmission or poor
hygienic procedure during delivery [19, 25].
In this study, GNB were the most common (87%, 39/44)
cause of both early and late onset sepsis, which corre-
sponds to findings in several LMICs [26, 27]. Among all
isolates, Klebsiella pneumonia was the most common iso-
late, similar to observations in other NICUs [25, 26]. In
fact, this bacteria has been a predominantly persisting
etiologic agent of sepsis outbreaks in Patan hospital NICU
requiring intermittent shut down of the unit [28, 29]. In-
creasing AMR of clinical Enterobacteriaceae isolates is a
global public health threat [30]. Due to the extensive use
of broad spectrum antimicrobials, NICUs are likely to play
a major role in the emergence and spread of MDR organ-
isms [31]. In our study, 72% of isolates were MDR and
higher proportion of GNB isolates were resistant to third
generation cephalosporins (72%) and meropenem (34%),
as reported in several NICUs of LMICs [27, 32, 33]. This
is in contrary to studies from other regions like Southeast
Asia [23], Africa [34] and Latin America [35],where below
10% of isolates were resistant to carbapenems despite
higher proportion of resistance to extended spectrum
cephalosporins. Beta-lactam antimicrobials are the
mainstay for therapeutic management of sepsis. Higher
percentage of AMR phenotypes of GNB and possessing
genetic determinants conferring potentially transferable
resistance to all available beta-lactams portrays a formid-
able therapeutic challenge. We found that nearly half of
GNB isolates carried blaTEM ESBL gene and blaKPC
carbapenemase genes; similar to that in some Indian
studies [33, 36, 37].
Here, at least 80% of sepsis episodes were NICU
acquired as they developed after 48 h of NICU ad-
mission. This is further corroborated by the facts
that we enrolled only the inborne neonates who
were never discharged from Patan hospital after
birth and had no apparent signs of infection at the
time of admission. This strongly suggests that these
infections were acquired horizontally from the envir-
onment during their stay in NICU. Further, due to
constrain of resources, a physically separated area
was not available to entirely isolate the culture posi-
tive cases in our unit during the study period.
Though two beds in NICU were dedicated for the care
of culture positive neonates, being inside the same
NICU unit, the sharing of human and medical re-
sources could not be avoided. A proper aseptic cleaning
of medical devices and proper hand hygiene was prac-
ticed as much as possible before sharing the resources
between septic and non-septic neonates residing in the
same unit. However, an absolute seclusion might not
have achieved leading to massive cross infection events
from infected to non-infected neonates. Thus, during
the study period, the burden of infection was high in
our unit and a majority of infections were environmen-
tally acquired. This is a common scenario in several re-
source strapped hospitals of LMICs. In our study, we
found that with every single day increase in the use of
invasive devices such as mechanical ventilation, IV can-
nula, central vascular lines (UAC, UVC) and every add-
itional event of blood transfusion, the odds of
developing sepsis were increased by ratios of 1.09, 1.14,
1.37, 1.32 and 3.08 respectively. The use of umbilical
catheterization [6, 38, 39] and mechanical ventilation
[5, 39] were also significantly associated with sepsis in
other studies. While invasive procedures are integral
components of neonatal care in NICU, these life-
sustaining devices often simultaneously serve as portals
of systemic infections as observed in our study. Our
findings thus emphasize the need to strengthen local
infection control measures such as hand hygiene; and
aseptic placement and maintenance procedures for in-
vasive devices. Additionally, the removal of invasive de-
vices whenever possible to reduce their dwelling time
may be one of the factors in reducing the prevalence of
sepsis. Here, we also found that every additional day of
stay in NICU and hospital increased the risk of sepsis
development with odds of 1.109 and 1.097 respectively,
as observed in other studies [6, 40]. An increased stay
in NICU and other hospital wards invariably raises the
exposure to various nosocomial risk factors such as
handling, device uses etc., thereby increasing the occur-
rence of sepsis. This consequently may increase other
health complications and overall health care cost.
Hence, it is suggested that the unnecessarily protracted
NICU or hospital stay for the neonates should be
avoided as far as possible to reduce the sepsis
incidences.
Breast milk has been considered to have a protect-
ive effect against infections due to its anti-infective,
microbiome-modulating, and immune-stimulatory
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properties [41–43]. In this study, we found that every
single day increase in failure to breast feeding during
the study period significantly increased the odds of
sepsis with odds ratio of 1.13, as with failure to spoon
feeding (OR 1.14). Conversely, each day increase in
enteral feeding with OG tube during their NICU stay
also increased the risk of sepsis development with an
odds ratio of 1.163. Breast or spoon feeding may not
be possible in some NICU admitted neonates due to
several underlying conditions. However, our study
suggests that shortening the duration of enteral feed-
ing as much as possible and conversely switching to
oral feeding whenever possible may help in reducing
the occurrence of sepsis.
Besides being 1.5 years long and one of few prospective
longitudinal studies from Nepal on neonatal sepsis, another
strength of our study is the investigation of AMR genes,
which is limited to phenotypic AMR profile only in other
studies from Nepal. Given the increasing burden of MDR
pathogens in NICUs, it becomes imperative to investigate
pathogens for presence of AMR genes so that it aids in
selecting optimal antimicrobial therapies. Further, our abil-
ity to convince the hospital administration to build a phys-
ically separated isolation room with NICU facility (NISO,
Neonatal ICU Isolation room) based on the results of this
study is one of the greatest achievements of our study.
Since after the advent of NISO room which was developed
soon following our study for handling the culture-positive
neonates only, the incidence of sepsis has drastically re-
duced in our unit. Our study has few limitations too. We
might not have captured a complete picture of the epidemi-
ology and transmission dynamics of neonatal sepsis because
the follow up of enrolled neonates was restricted only to
the NICU irrespective of their further destiny (discharge or
transfer to other hospital wards). Majority (86/142) of en-
rolled neonates were directly admitted to NICU soon after
their birth. Depending on their prior clinical course, others
were however admitted to NICU after being kept in nursery
or mother’s ward postnatally. Though neonates did not
have any apparent signs of infection at the time of NICU
admission, we could not detect any incubating colonization
or infection and thus could not assure that all observed in-
fections were acquired solely from NICU. Further, fungal
sepsis etiology, environmental source on infections and
compliance to hand hygiene were not measured.
Conclusions
Our study determined the burden; demographic, clinical
and laboratory parameters; etiology; phenotypic and gen-
etic profile of AMR, and risk factors for NICU linked
neonatal sepsis in the low resource setting of Nepal.
High burden of neonatal sepsis and associated anti-
microbial resistance was documented. Further, it was ev-
idenced that majority of sepsis episodes were late-onset
and hospital acquired with the odds of sepsis being
raised with prolong insertion several invasive devices of
neonatal care. These findings can aid in an early identifi-
cation of high-risk neonates and in selecting an optimal
antimicrobial therapy in similar settings. It also empha-
sizes the need to conduct infection surveillance and im-
prove infection control measures. The accommodation
of extensive environmental investigation to pinpoint the
source and interventional approach to further validate
preventable risk factors are warranted in further studies.
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